2001•Seminars in HematologyRequires access

Molecular studies in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors

Charles L. Sawyers

Open publisher page 21 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 21 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Imatinib mesylate, Myeloid leukemia, Imatinib, Tyrosine kinase, Cancer research, Philadelphia chromosome, Tyrosine-kinase inhibitor, ABL

Back to paper search Browse research topics Original source

Molecular studies in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors — Research Paper | ScholarLens